Table 1 Baseline characteristics of patients
Parameter | Total (%) |
|---|---|
Sex | 17 |
Male | 10 (58.8%) |
Female | 7 (41.2%) |
Age (years) | |
Mean ± SD | 60.14 ± 6.36 |
Eye | |
OD | 8 (47.1%) |
OS | 9 (52.9%) |
RVO type | |
BRVO | 10 (58.8%) |
CRVO | 7 (41.2%) |
Time to injection (months)a | |
Median (range) | 4.5 (2–13) |
Previous bevacizumab injections (n) | |
Median (range) | 7 (3–18) |